Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

66 trials with published results (6%)

Research Maturity

508 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.7%

58 terminated out of 1023 trials

Success Rate

89.8%

+3.2% vs benchmark

Late-Stage Pipeline

11%

110 trials in Phase 3/4

Results Transparency

13%

66 of 508 completed with results

Key Signals

66 with results90% success58 terminated

Data Visualizations

Phase Distribution

503Total
Not Applicable (281)
Early P 1 (7)
P 1 (25)
P 2 (80)
P 3 (38)
P 4 (72)

Trial Status

Completed508
Unknown167
Recruiting131
Not Yet Recruiting77
Terminated58
Withdrawn40

Trial Success Rate

89.8%

Benchmark: 86.6%

Based on 508 completed trials

Clinical Trials (1023)

Showing 20 of 20 trials
NCT07760129Not Yet RecruitingPrimary

Erector Spinae Oxygen Saturation and AKI After OPCAB

NCT07751913Not Yet RecruitingPrimary

ProNephro NGAL Test for Early Detection of Acute Kidney Injury in Adult ICU Patients (ALPACA)

NCT07718373Not Yet RecruitingPrimary

Early Postoperative L-arginine and Acute Kidney Injury After Cardiac Surgery

NCT07751861Not ApplicableCompletedPrimary

Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy: A Pragmatic Randomized Trial

NCT07751874Not Yet RecruitingPrimary

A Prospective, Observational Study to Evaluate the Safety and Feasibility of Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation in a Cohort Critical Ill Patients With Acute Kidney Injury and Presumed Absent Citrate Metabolism

NCT04403633Not ApplicableRecruitingPrimary

A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention

NCT07749417RecruitingPrimary

Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.

NCT06248359CompletedPrimary

Association Between Postoperative Administration of L-Arginine and CSA-AKI

NCT07746063CompletedPrimary

Body Composition, Kidney Size, and Medication Dosing in Acute Kidney Injury: Follow-Up at 90 Days and 12 Months

NCT07518992Completed

Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction

NCT07743099Completed

Renal and Cerebral NIRS and Early Acute Kidney Injury in Cooled Neonates With Birth Asphyxia

NCT07738328Phase 2Not Yet RecruitingPrimary

Terbinafine for CSA-AKI Prevention

NCT07739290Not ApplicableNot Yet RecruitingPrimary

NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

NCT07215702Phase 2Recruiting

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

NCT07324694Recruiting

Impact of Intraoperative Hemodynamic Instability on Outcomes in Cardiac Surgery

NCT07734636Phase 4Not Yet RecruitingPrimary

A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury

NCT06251713Not ApplicableRecruitingPrimary

Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery

NCT07212595Phase 2RecruitingPrimary

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

NCT07718464RecruitingPrimary

FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

NCT07719569Not Yet RecruitingPrimary

Treatment Costs of Kidney Injury in Patients Having Heart Surgery in the UK

Scroll to load more

Research Network

Activity Timeline